What are the survival rates for locally advanced Thyroid Cancer
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Survival Rates for Locally Advanced Thyroid Cancer
I appreciate this important question. Let me explain what we know about survival for locally advanced thyroid cancer, keeping in mind that thyroid cancer outcomes vary significantly based on several factors.
Understanding "Locally Advanced"
Locally advanced thyroid cancer means the tumor has grown beyond the thyroid gland itself—it may have invaded surrounding tissues in the neck or spread to nearby lymph nodes, but hasn't spread to distant organs like the lungs or bones.
What the Evidence Shows
According to the NCCN Guidelines for Thyroid Carcinoma, survival outcomes for locally advanced disease depend heavily on:
Key Prognostic Factors:
- Patient age (patients under 55 generally have better outcomes)
- Tumor size and extent (how much it has invaded surrounding structures)
- Lymph node involvement (whether cancer has spread to neck lymph nodes)
- Whether the cancer is iodine-responsive (can be treated with radioactive iodine)
- Response to initial treatment (surgery, radioactive iodine, and/or radiation therapy)
Specific Survival Data
The NCCN Guidelines reference several prognostic scoring systems. For example, using the MACIS score (which considers Metastasis, Age, Completeness of resection, Invasion, and Size):
- MACIS score <6: 20-year survival rate of 99%
- MACIS score 6-6.99: 20-year survival rate of 89%
- MACIS score 7-7.99: 20-year survival rate of 56%
- MACIS score 8+: 20-year survival rate of 24%
However, it's important to note that these are general statistics—your individual prognosis depends on your specific clinical situation.
Treatment Approaches for Locally Advanced Disease
According to NCCN Guidelines, locally advanced thyroid cancer typically involves:
- Total thyroidectomy (complete removal of the thyroid)
- Lymph node dissection (removal of involved lymph nodes)
- Radioactive iodine (RAI) therapy (if the cancer takes up iodine)
- External beam radiation therapy (EBRT) - particularly for:
- Tumors with extrathyroidal extension (growing outside the thyroid)
- Lymph node involvement
- Incomplete surgical removal
The NCCN Guidelines note that adjuvant (additional) external beam radiation therapy has shown benefits in reducing local recurrence and improving survival in select patients with locally advanced disease.
Important Context
Response to initial treatment is a major predictor. The NCCN Guidelines emphasize that how well your cancer responds to surgery and radioactive iodine in the first year after diagnosis is actually more predictive of long-term outcomes than the initial staging alone. This is called "risk stratification based on response to therapy."
Questions to Ask Your Oncology Team
Since survival rates vary so much based on individual factors, I'd recommend asking your healthcare team:
- What is my specific risk category based on my tumor characteristics and pathology report?
- What is the expected survival rate for someone with my specific type and stage of thyroid cancer?
- What treatment plan do you recommend, and how does it affect my prognosis?
- How will we monitor my response to treatment, and what does a good response look like?
- What follow-up schedule should I expect, and what signs should I watch for?
The Bottom Line
Locally advanced thyroid cancer has variable outcomes, but many patients—especially younger patients—achieve excellent long-term survival with appropriate multimodal treatment (surgery, radioactive iodine, and sometimes radiation therapy). Your individual prognosis depends on multiple factors that your oncology team can assess based on your complete clinical picture.
According to the NCCN Guidelines for Thyroid Carcinoma, the approach to locally advanced disease emphasizes risk-adapted management, meaning your treatment will be tailored to your specific risk factors rather than using a one-size-fits-all approach.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions about your specific situation.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Thyroid Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with prognosis for Thyroid Cancer patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: